Homology Medicines (FIXX) Financial Statements
Price: $0.9347
Market Cap: $3.02M
Avg Volume: 29.54K
Market Cap: $3.02M
Avg Volume: 29.54K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Homology Medicines.
Income Statement
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.16M | $3.21M | $33.97M | $2.70M | $1.67M | $3.68M | $- | $- |
| Cost of Revenue | $578.00K | $2.60M | $9.54M | $100.39M | $89.40M | $- | $- | $- |
| Gross Profit | $578.00K | $609.00K | $24.43M | $-97.69M | $-87.73M | $3.68M | $- | $- |
| Gross Profit Ratio | 50.00% | 18.98% | 71.90% | -3615.47% | -5266.03% | 100.00% | 0.00% | 0.00% |
| Research and Development Expenses | $62.00M | $98.35M | $93.08M | $100.39M | $89.40M | $47.95M | $21.38M | $5.69M |
| General and Administrative Expenses | $31.26M | $38.14M | $36.84M | $32.57M | $22.21M | $17.30M | $8.28M | $4.31M |
| Selling and Marketing Expenses | $-578.00K | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $30.68M | $38.14M | $36.84M | $32.57M | $22.21M | $17.30M | $8.28M | $4.31M |
| Other Expenses | $9.33M | $- | $- | $- | $- | $- | $-876.00K | $1.93M |
| Operating Expenses | $92.68M | $136.49M | $129.92M | $132.97M | $111.61M | $65.25M | $29.66M | $10.00M |
| Cost and Expenses | $93.26M | $136.49M | $129.92M | $132.97M | $111.61M | $65.25M | $29.66M | $10.00M |
| Interest Income | $5.58M | $3.23M | $185.00K | $1.57M | $6.03M | $4.35M | $542.63K | $24.20K |
| Interest Expense | $- | $- | $- | $- | $- | $- | $- | $- |
| Depreciation and Amortization | $578.00K | $-129.96M | $8.35M | $7.96M | $6.32M | $1.29M | $684.21K | $239.80K |
| EBITDA | $-91.52M | $-133.28M | $-87.60M | $-122.30M | $-103.62M | $-60.27M | $-28.97M | $-9.76M |
| EBITDA Ratio | -7917.30% | -4155.00% | -257.86% | -4526.20% | -6219.99% | -1636.13% | 0.00% | 0.00% |
| Operating Income | $-92.10M | $-133.28M | $-95.95M | $-130.26M | $-109.94M | $-61.56M | $-29.66M | $-10.00M |
| Operating Income Ratio | -7967.30% | -4154.64% | -282.44% | -4820.98% | -6599.22% | -1671.12% | 0.00% | 0.00% |
| Total Other Income Expenses Net | $14.35M | $134.48M | $185.00K | $1.57M | $6.03M | $4.35M | $-333.37K | $1.95M |
| Income Before Tax | $-87.08M | $1.20M | $-95.76M | $-128.69M | $-103.92M | $-57.22M | $-29.99M | $-8.05M |
| Income Before Tax Ratio | -7532.87% | 37.34% | -281.90% | -4762.92% | -6237.45% | -1553.07% | 0.00% | 0.00% |
| Income Tax Expense | $25.88M | $715.00K | $-185.00K | $-1.57M | $-6.03M | $4.35M | $-542.63K | $-24.20K |
| Net Income | $-112.96M | $483.00K | $-95.58M | $-127.12M | $-97.89M | $-57.22M | $-29.99M | $-8.05M |
| Net Income Ratio | -9771.71% | 15.06% | -281.35% | -4704.85% | -5875.69% | -1553.07% | 0.00% | 0.00% |
| EPS | $-351.57 | $1.51 | $-311.20 | $-498.41 | $-418.35 | $-360.70 | $-159.96 | $-77.86 |
| EPS Diluted | $-351.57 | $1.51 | $-311.20 | $-498.41 | $-418.35 | $-360.70 | $-159.96 | $-77.86 |
| Weighted Average Shares Outstanding | 321.30K | 318.89K | 307.13K | 255.06K | 233.99K | 158.62K | 187.49K | 103.35K |
| Weighted Average Shares Outstanding Diluted | 321.30K | 318.89K | 307.13K | 255.06K | 233.99K | 158.62K | 187.49K | 103.35K |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $39.27M | $33.99M | $108.38M | $217.43M | $53.77M | $38.22M | $51.57M | $11.39M |
| Short Term Investments | $43.39M | $141.04M | $47.49M | $- | $208.61M | $176.52M | $78.08M | $- |
| Cash and Short Term Investments | $82.65M | $175.03M | $155.87M | $217.43M | $262.39M | $214.74M | $129.66M | $11.39M |
| Net Receivables | $- | $- | $- | $400.00K | $400.00K | $- | $- | $- |
| Inventory | $- | $- | $- | $1 | $2 | $- | $- | $- |
| Other Current Assets | $1.26M | $5.99M | $36.04M | $1.73M | $3.79M | $6.95M | $1.94M | $481.79K |
| Total Current Assets | $83.91M | $181.01M | $191.91M | $219.56M | $266.58M | $221.69M | $131.60M | $11.99M |
| Property Plant Equipment Net | $650.00K | $21.64M | $17.86M | $42.90M | $42.72M | $35.64M | $3.15M | $1.96M |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $25.81M | $1.95M | $1.27M | $1.27M | $- | $- | $- |
| Tax Assets | $221.56M | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $- | $-47.45M | $- | $- | $- | $1.77M | $2.77M | $276.00K |
| Total Non-Current Assets | $222.21M | $47.45M | $19.81M | $44.17M | $43.99M | $37.41M | $5.93M | $2.23M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $306.12M | $228.47M | $211.72M | $263.74M | $310.57M | $259.09M | $137.53M | $14.22M |
| Account Payables | $3.23M | $1.14M | $2.37M | $4.72M | $2.61M | $15.73M | $2.54M | $893.67K |
| Short Term Debt | $1.32M | $1.56M | $246.00K | $2.50M | $- | $- | $- | $- |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $1.16M | $3.21M | $5.63M | $809.00K | $3.68M | $3.34M | $- |
| Other Current Liabilities | $7.02M | $18.71M | $11.41M | $9.80M | $8.96M | $6.02M | $2.98M | $5.48M |
| Total Current Liabilities | $11.57M | $22.58M | $17.23M | $22.66M | $12.37M | $25.43M | $8.86M | $6.38M |
| Long Term Debt | $- | $27.92M | $23.69M | $12.94M | $- | $- | $- | $- |
| Deferred Revenue Non-Current | $- | $- | $1.16M | $32.14M | $30.14M | $29.47M | $30.07M | $- |
| Deferred Tax Liabilities Non-Current | $221.56M | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $-221.56M | $- | $- | $- | $9.54M | $9.47M | $290.92K | $17.73M |
| Total Non-Current Liabilities | $221.55M | $27.92M | $24.84M | $45.08M | $39.69M | $38.94M | $30.36M | $17.73M |
| Other Liabilities | $1 | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $233.13M | $50.49M | $42.07M | $67.74M | $52.06M | $64.38M | $39.22M | $24.11M |
| Preferred Stock | $- | $- | $- | $- | $- | $259.09M | $- | $- |
| Common Stock | $6.00K | $6.00K | $6.00K | $5.00K | $4.00K | $3.00K | $2.68K | $212 |
| Retained Earnings | $-542.10M | $-429.14M | $-424.13M | $-328.37M | $-199.67M | $-97.40M | $-40.18M | $-10.19M |
| Accumulated Other Comprehensive Income Loss | $-5.00K | $-404.00K | $-7.00K | $- | $183.00K | $-77.00K | $-73.31K | $- |
| Other Total Stockholders Equity | $615.09M | $607.51M | $593.78M | $524.36M | $457.99M | $292.19M | $138.56M | $21.94M |
| Total Stockholders Equity | $72.99M | $177.98M | $169.65M | $196.00M | $258.51M | $194.72M | $98.31M | $-9.89M |
| Total Equity | $72.99M | $177.98M | $169.65M | $196.00M | $258.51M | $194.72M | $- | $- |
| Total Liabilities and Stockholders Equity | $306.12M | $228.47M | $211.72M | $263.74M | $310.57M | $259.09M | $137.53M | $14.22M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $306.12M | $228.47M | $211.72M | $263.74M | $310.57M | $259.09M | $137.53M | $14.22M |
| Total Investments | $43.39M | $166.85M | $47.49M | $1.27M | $208.61M | $176.52M | $78.08M | $- |
| Total Debt | $1.32M | $29.48M | $23.93M | $15.44M | $- | $- | $- | $- |
| Net Debt | $-37.95M | $-4.51M | $-84.45M | $-201.99M | $-53.77M | $-38.22M | $-51.57M | $-11.39M |
Cash Flow Statement
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $-112.96M | $-5.00M | $-95.76M | $-128.69M | $-103.92M | $-57.22M | $-29.99M | $-8.05M |
| Depreciation and Amortization | $578.00K | $1.29M | $8.35M | $7.96M | $6.32M | $1.29M | $684.21K | $239.80K |
| Deferred Income Tax | $-2.09M | $- | $1.03M | $690.00K | $- | $- | $-85.74K | $- |
| Stock Based Compensation | $7.32M | $13.05M | $17.25M | $13.25M | $7.63M | $2.62M | $277.20K | $162.28K |
| Change in Working Capital | $-7.21M | $3.35M | $-41.80M | $11.52M | $463.00K | $12.20M | $34.72M | $928.48K |
| Accounts Receivables | $- | $- | $- | $- | $- | $- | $- | $- |
| Inventory | $- | $- | $- | $- | $- | $- | $- | $- |
| Accounts Payables | $2.09M | $-981.00K | $-2.49M | $2.46M | $-4.45M | $4.38M | $1.72M | $517.97K |
| Other Working Capital | $-9.30M | $4.33M | $-39.32M | $9.06M | $4.92M | $7.82M | $33.00M | $410.51K |
| Other Non Cash Items | $18.13M | $-126.35M | $1.19M | $939.00K | $-1.86M | $-1.46M | $876.00K | $-1.77M |
| Net Cash Provided by Operating Activities | $-96.23M | $-113.66M | $-109.75M | $-94.33M | $-91.36M | $-42.56M | $6.48M | $-8.48M |
| Investments in Property Plant and Equipment | $-228.00K | $-1.28M | $-2.40M | $-3.73M | $-21.83M | $-24.94M | $-1.96M | $-1.99M |
| Acquisitions Net | $554.00K | $130.00M | $48.39M | $-208.63M | $29.97M | $- | $- | $- |
| Purchases of Investments | $-73.24M | $-157.46M | $-97.39M | $-19.99M | $-286.39M | $-245.33M | $-78.07M | $- |
| Sales Maturities of Investments | $174.24M | $65.46M | $49.00M | $228.62M | $256.43M | $148.48M | $- | $- |
| Other Investing Activities | $554.00K | $38.00M | $-48.39M | $208.63M | $-29.97M | $- | $-1.50M | $-276.00K |
| Net Cash Used for Investing Activities | $101.33M | $36.72M | $-50.79M | $204.90M | $-51.80M | $-121.79M | $-81.53M | $-2.27M |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $184.00K | $- | $- | $- | $- | $- | $- | $378.31K |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $-17.47K | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $184.00K | $596.00K | $52.17M | $53.09M | $158.21M | $150.99M | $115.23M | $378.31K |
| Net Cash Used Provided by Financing Activities | $184.00K | $596.00K | $52.17M | $53.09M | $158.21M | $150.99M | $115.23M | $378.31K |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $5.28M | $-76.35M | $-108.37M | $163.66M | $15.06M | $-13.36M | $40.18M | $-10.37M |
| Cash at End of Period | $39.27M | $33.99M | $110.33M | $218.71M | $55.05M | $38.22M | $51.57M | $11.39M |
| Cash at Beginning of Period | $33.99M | $110.33M | $218.71M | $55.05M | $39.99M | $51.58M | $11.39M | $21.76M |
| Operating Cash Flow | $-96.23M | $-113.66M | $-109.75M | $-94.33M | $-91.36M | $-42.56M | $6.48M | $-8.48M |
| Capital Expenditure | $-228.00K | $-1.28M | $-2.40M | $-3.73M | $-21.83M | $-24.94M | $-1.96M | $-1.99M |
| Free Cash Flow | $-96.46M | $-114.95M | $-112.15M | $-98.06M | $-113.19M | $-67.50M | $4.52M | $-10.47M |